GENETIC RISK FACTORS OF ANTHRACYCLINE CARDIOTOXICITY - RELEVANT POLYMORPHISMS IDENTIFIED IN ENZYMES AND TRANSPORTERS OF ANTHRACYCLINE PHARMACOKINETICS

被引：0
|
作者：
Kutszegi, Nora Zsofia [1 ]
Semsei, Agnes F. [1 ]
Lautner-Csorba, Orsolya [1 ]
Hegyi, Marta [2 ]
Szabolcs, Judit [2 ]
Benyo, Gabor [3 ]
Szalai, Csaba [1 ,4 ]
Kovacs, Gabor T. [2 ]
Erdelyi, Daniel Janos [2 ]
机构：
[1] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary
[2] Semmelweis Univ, Dept Paediat 2, H-1085 Budapest, Hungary
[3] Szent Laszlo Hosp, Budapest, Hungary
[4] Csertex Res Lab, Budapest, Hungary
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1101 / 1101
页数：1
相关论文
共 50 条
  • [11] Genotyping the risk of anthracycline-induced cardiotoxicity
    Shiwei Deng
    Leszek Wojnowski
    Cardiovascular Toxicology, 2007, 7 : 129 - 134
  • [12] Genotyping the risk of anthracycline-induced cardiotoxicity
    Deng, Shiwei
    Wojnowski, Leszek
    CARDIOVASCULAR TOXICOLOGY, 2007, 7 (02) : 129 - 134
  • [13] Identifying patients at high risk of anthracycline cardiotoxicity
    Reactions Weekly, 1997, 636 (1) : 4 - 4
  • [14] Anthracycline maintenance therapy limited by risk of cardiotoxicity
    不详
    Drugs & Therapy Perspectives, 1997, 10 (3) : 13 - 16
  • [15] Genetic factors in anthracycline-induced cardiotoxicity in patients treated for pediatric cancer
    Petrykey, Kateryna
    Andelfinger, Gregor U.
    Laverdiere, Caroline
    Sinnett, Daniel
    Krajinovic, Maja
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (10) : 865 - 883
  • [16] Effect of low-protein diet on anthracycline pharmacokinetics and cardiotoxicity
    El-Demerdash, Ebtehal
    Ali, Azza A.
    El-Taher, Dalia E. M.
    Hamada, Farid M. A.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (03) : 344 - 352
  • [17] Anthracycline- Induced Cardiotoxicity: the Role of Genetic Predictors
    Kopeva, K., V
    Grakova, E., V
    Shilov, S. N.
    Popova, A. A.
    Berezikova, E. N.
    Neupokoeva, M. N.
    Ratushnyak, E. T.
    Teplyakov, A. T.
    KARDIOLOGIYA, 2023, 63 (04) : 22 - 28
  • [18] Late anthracycline cardiotoxicity and genetic alteration of iron metabolism
    Irun, Alvaro Pena
    Botin, Eva Bengochea
    Rodrigo, Emilio Pariente
    MEDICINA CLINICA, 2022, 158 (10): : 499 - 500
  • [19] Anthracycline-related cardiotoxicity:: risk factors and therapeutic options in childhood cancers
    Puma, Nadia
    Ruggiero, Antonio
    Ridola, Vita
    Maurizi, Palma
    Lazzareschi, Ilaria
    Attina, Giorgio
    Mastrangelo, Stefano
    De Rosa, Gabriella
    Riccardi, Riccardo
    SIGNA VITAE, 2008, 3 (01) : 30 - 34
  • [20] Cardioactive molecules identified by functional in vivo screening prevent anthracycline cardiotoxicity
    Bortolotti, Francesca
    Mura, Antonio
    Riccio, Matteo Maria
    Dal Ferro, Matteo
    Zentilin, Lorena
    Giacca, Mauro
    CIRCULATION RESEARCH, 2024, 135
12345